Newport Beach, Calif. (November 5, 2018) – CureDuchenne, a global leader in research, patient care, and innovation in improving and extending the lives of those living with Duchenne muscular dystrophy […]
Investment advances pre-clinical development of novel exon skipping therapies for treatment of patients with Duchenne muscular dystrophy October 17, 2018 08:00 AM Eastern Daylight Time LA JOLLA, Calif.–(BUSINESS WIRE)–Avidity Biosciences, […]
Nonprofit invests in leading specialty prescription and prior authorization solution provider to get Duchenne patients breakthrough medications, faster October 17, 2018 08:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–ZappRx, Inc., a […]
UNIVERSITY CITY (WPVI) — Philadelphia’s well-known for medical research, with thousands of people in our city working in that field. Recently, a high schooler got time in a professional […]
Dear Duchenne Advocacy Leaders, Lately we have heard many stop to consider the progress made in the last decade in Duchenne treatment and care. Improvements have been driven by this […]
ORANGE COUNTY BUSINESS JOURNAL Paul Miller, co-founder of the CureDuchenne nonprofit group and chief operating officer of Irvine-based Patman Meat Group, recalls the first time he met the woman who would […]
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Caregivers of Duchenne muscular dystrophy and patients suffering from the rare disease on the east coast will have an opportunity to learn about the best practices of […]
Highlights from day three at the World Muscle Society meeting in Mendoza, Argentina, provided by CureDuchnne’s scientist, Dr. Mike Kelly. Mallinckrodt Pharmaceuticals Mallinckrodt provided an update on their Phase 2 […]
Highlights from day two at the World Muscle Society meeting in Mendoza, Argentina, provided by CureDuchnne’s scientist, Dr. Mike Kelly. Sarepta’s Gene Therapy Program: Sarepta provided a much-anticipated update on […]
